StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) to sell $19 billion of bonds to fund Celgene (CELG) deal - Bloomberg
May 7, 2019 1:20 PM
Bristol-Myers Squibb (NYSE: BMY) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Mergers and Acquisitions
Trader Talk